| Witkowski, Piotr |
NCT01241864: Islet Transplantation in Type 1 Diabetic Kidney Allograft |
|
|
| Recruiting | 2 | 10 | US | Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells | University of Chicago | Diabetes Mellitus, Type 1 | 12/25 | 12/25 | | |
NCT06305286: Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D) |
|
|
| Recruiting | 1/2 | 9 | US | AT-1501 | University of Chicago, Juvenile Diabetes Research Foundation, Cure Alliance | Diabetes Mellitus | 03/29 | 03/29 | | |
| Recruiting | 1/2 | 5 | US | Belatacept Injection, proteasome inhibitor | University of Chicago | Kidney Transplantation, End Stage Kidney Disease (ESRD) | 09/26 | 12/26 | | |
NCT03513939: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation |
|
|
| Recruiting | 1/2 | 17 | US | Sernova Cell Pouch | Sernova Corp, ICON plc, University of Chicago, Breakthrough T1D | Type 1 Diabetes Mellitus | 10/26 | 10/28 | | |
| Active, not recruiting | 1/2 | 50 | US | Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells | University of Chicago | Diabetes Mellitus, Type 1 | 10/25 | 10/25 | | |
NCT01630850: Islet Transplantation in Patients With "Brittle" Type I Diabetes |
|
|
| Recruiting | N/A | 20 | US | Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells | University of Chicago | Diabetes Mellitus, Type 1 | 09/25 | 06/30 | | |
